AR004338A1 - USE OF A PROTEIN DERIVED FROM A CHEMIOKIN TO PREPARE A MEDICATION TO TREAT AND PREVENT SEPSIS. - Google Patents

USE OF A PROTEIN DERIVED FROM A CHEMIOKIN TO PREPARE A MEDICATION TO TREAT AND PREVENT SEPSIS.

Info

Publication number
AR004338A1
AR004338A1 ARP960105280A ARP960105280A AR004338A1 AR 004338 A1 AR004338 A1 AR 004338A1 AR P960105280 A ARP960105280 A AR P960105280A AR P960105280 A ARP960105280 A AR P960105280A AR 004338 A1 AR004338 A1 AR 004338A1
Authority
AR
Argentina
Prior art keywords
prepare
treat
chemiokin
medication
protein derived
Prior art date
Application number
ARP960105280A
Other languages
Spanish (es)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Priority to ARP960105280A priority Critical patent/AR004338A1/en
Publication of AR004338A1 publication Critical patent/AR004338A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Uso de quimioquinas seleccionadas de KC madura o modificada [SEQ ID N°1], gro alfa [SEC.ID. N° 2] gro beta [SEC ID. N° 3] o gro gamma [SEC ID N°: 4] osus multímeros, solos o junto con un agente anti-infeccioso para preparar un medicamento, para prevenir y tratar la sepsis.Use of selected chemokines from mature or modified KC [SEQ ID No. 1], alpha gro [SEQ.ID. No. 2] gro beta [SEQ ID. No. 3] or gro gamma [SEQ ID NO: 4] osus multimers, alone or together with an anti-infective agent to prepare a medicine, to prevent and treat sepsis.

ARP960105280A 1996-11-21 1996-11-21 USE OF A PROTEIN DERIVED FROM A CHEMIOKIN TO PREPARE A MEDICATION TO TREAT AND PREVENT SEPSIS. AR004338A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP960105280A AR004338A1 (en) 1996-11-21 1996-11-21 USE OF A PROTEIN DERIVED FROM A CHEMIOKIN TO PREPARE A MEDICATION TO TREAT AND PREVENT SEPSIS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP960105280A AR004338A1 (en) 1996-11-21 1996-11-21 USE OF A PROTEIN DERIVED FROM A CHEMIOKIN TO PREPARE A MEDICATION TO TREAT AND PREVENT SEPSIS.

Publications (1)

Publication Number Publication Date
AR004338A1 true AR004338A1 (en) 1998-11-04

Family

ID=51983161

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960105280A AR004338A1 (en) 1996-11-21 1996-11-21 USE OF A PROTEIN DERIVED FROM A CHEMIOKIN TO PREPARE A MEDICATION TO TREAT AND PREVENT SEPSIS.

Country Status (1)

Country Link
AR (1) AR004338A1 (en)

Similar Documents

Publication Publication Date Title
ES2130428T3 (en) INSULIN CRYSTALS ASP-B28.
GT199800126A (en) COMBINATION THERAPY.
DE69514342T2 (en) MODIFIED POLYPEPTIDES WITH INCREASED BIOLOGICAL ACTIVITY
LTC1131065I2 (en) Dialkyl fumarates for the treatment of autoimmune diseases
FI946004A0 (en) Thrombin blood fraction used in a medical procedure
ATE380875T1 (en) CHIMERIC PROTEINS TO AVOID COMPLEMENT ACTIVATION
IT8619338A0 (en) SYNTHETIC PEPTIDE WITH HUMAN INTERLEUKIN 1 ACTIVITY.
DE3587479D1 (en) VEHICLE FOR ADMINISTERING INTERFERON.
ATE177757T1 (en) IMPROVED IMMUNOGENIC COMPOSITION AGAINST HUMAN GASTRIN 17
UA65561A (en) Therapeutic agent for lymphatic tumors
DK0669979T3 (en) C-C CKR-1, chemokine receptor
DE3769707D1 (en) THERAPEUTIC SYSTEM WITH REGULATED DELIVERY OF ACTIVE SUBSTANCES.
HUP0000432A2 (en) Insulin c-peptides
DE69518760T2 (en) GROWTH DIFFERENTIATION FACTOR-12
ES2146214T3 (en) VACCINES FOR ACTINOBACILLUS PLEUROPNEUMONIAE.
RS49599B (en) Use of h+, k+ -atpaze inhibitors and glucocortifoids and pharmaceutical formulation
AR004338A1 (en) USE OF A PROTEIN DERIVED FROM A CHEMIOKIN TO PREPARE A MEDICATION TO TREAT AND PREVENT SEPSIS.
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
BR0012006A (en) Method to prevent inflammation, autoimmune diseases and tumor growth, and use of substances that suppress ltbr-mediated activation
SE9502219D0 (en) Novel medical use
ES2171157T3 (en) RECOMBINANT CODING GENE FOR A PROTEIN WITH ENDOQUITINASA ACTIVITY.
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
DK0542869T3 (en) Tissue plasminogen activator variants with decreased secretion
DE59609353D1 (en) Agent for subcutaneous administration of protein C.
IT8721455A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE THERAPY OF PATHOPHYSIOLOGICAL STATES WITH INCREASED PROTEIN CATABOLISM.